New diabetes drug tested in patients with liver disease – no cure expected
NCT ID NCT07193147
First seen Nov 01, 2025 · Last updated Apr 24, 2026 · Updated 21 times
Summary
This early-stage study tests a single dose of the experimental drug GZR4 in 36 adults with diabetes who also have mild, moderate, or severe liver impairment. The goal is to see how the drug moves through the body and whether it is safe in these patients. This study does not aim to treat or cure diabetes, but to gather important safety information for future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gan & Lee Pharmaceuticals Shandong Co., Ltd.
Linyi, Shandong, 276000, China
Conditions
Explore the condition pages connected to this study.